Skip to content

Centromere Antibody (Serum) - Autoimmune Antibody Profile

Published: August 9, 2026Updated: August 15, 2026

This test measures antibodies against centromere proteins, which may indicate a rare autoimmune disorder called limited cutaneous systemic sclerosis (lcSSc).

Quick summary

["This test helps diagnose or monitor a specific type of scleroderma."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 15, 2026Editorial policy

Key facts at a glance

LOINC
53981-7
Short code
CENTB
Synonyms
Centromere B Ab Ser Ql
Category
chemistry
Sample
serum
Container
Serum separator tube (SST) or red top tube with clot activator
Units
N/A
Ref low
0
Ref high
1
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
Enzyme-linked immunosorbent assay (ELISA) or Multiplex bead-based immunoassay
CPT
83516
SNOMED
37725009
Specimen volume
1.0 mL serum (minimum 0.5 mL)
Stability
Room temperature: 8 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): 30 days. Avoid repeated freeze-thaw cycles.
Hemolysis max
200
Lipemia max
100
Icterus max
20
TAT
24–72 hours
Order
routine

What Is This Test Measuring?

The test detects the presence of antibodies targeting centromere proteins found in cells. These antibodies are linked to a subset of autoimmune diseases affecting the skin and connective tissues.

Why Might Your Doctor Order This Test?

Your doctor may recommend this test if you have symptoms like skin tightening, Raynaud’s phenomenon, or other signs of limited cutaneous systemic sclerosis (lcSSc), a form of scleroderma. It can also help confirm a diagnosis or assess disease activity.

How Is the Sample Collected?

A blood sample is drawn from a vein in your arm. The blood is processed to separate serum, which is then tested for centromere antibodies.

What Are Common Symptoms to Watch For?

Symptoms of conditions this test may help identify include skin hardening and thickening (especially on hands, face, or arms), joint pain, Raynaud’s phenomenon (fingers/toes turning white/blue in cold), or digestive issues.

Reference range

Negative: <1.0 AI (Antibody Index) or negative by IFA at 1:40 dilution; Positive: ≥1.0 AI or positive titerN/A

Specimen: serum

No special patient preparation required. Fasting is not necessary.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

Centromere Antibody

Frequently asked questions

What does a positive result mean?
A positive result suggests a higher likelihood of limited cutaneous systemic sclerosis (lcSSc) or related autoimmune activity. However, further evaluation by a healthcare provider is needed to interpret results in the context of your symptoms and medical history.
Can this test be used to monitor disease progression?
Yes, this test can help track disease activity or progression in some cases, but results should be reviewed alongside clinical symptoms and other diagnostic criteria.
Are there any risks or side effects from this blood test?
The most common side effect is mild bruising or soreness at the injection site. Rarely, there may be a slight reaction at the needle site, such as redness or swelling.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy